UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Percutaneous Biliary External–Internal Drainage for Malignant Obstruction of Self-Expanding Uncovered Metal Stents Placed for Hilar Carcinoma: Retrospective Analysis of Long-Term Outcome in 160 Patients

Journal of clinical interventional radiology isvir, 2020-04, Vol.4 (1), p.3-8

2020

Volltextzugriff (PDF)

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer

Digestive and liver disease, 2014-03, Vol.46 (3), p.270-275

2014

Volltextzugriff (PDF)

Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis

The American journal of gastroenterology, 2013-01, Vol.108 (1), p.152-155

2013

Volltextzugriff (PDF)

Our challenge is to adapt the organization of our system to the six stages of the epidemic to go beyond the COVID‐19 crisis

British journal of surgery, 2020-06, Vol.107 (7), p.e189-e189

2020

Volltextzugriff (PDF)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

British journal of cancer, 2017-09, Vol.117 (7), p.1017-1025

2017

Volltextzugriff (PDF)

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Digestive and liver disease, 2020-06, Vol.52 (6), p.597-603

2020

Volltextzugriff (PDF)

The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?

Oncology, 2020-11, Vol.98 (12), p.827-835

2020

Volltextzugriff (PDF)

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

British journal of cancer, 2021-08, Vol.125 (5), p.725-733

2021

Volltextzugriff (PDF)

Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

Hepatology (Baltimore, Md.), 2007-12, Vol.46 (6), p.1872-1882

2007

Volltextzugriff (PDF)

Circulating DNA changes are predictive of disease progression after transarterial chemoembolization

International journal of cancer, 2022-02, Vol.150 (3), p.532-541

2022

Volltextzugriff (PDF)

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

Digestive and liver disease, 2015-10, Vol.47 (10), p.884-890

2015

Volltextzugriff (PDF)

CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts

HPB (Oxford, England), 2019-05, Vol.21 (5), p.582-588

2019

Volltextzugriff (PDF)

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial

JAMA oncology, 2023-10, Vol.9 (10), p.1356

2023

Volltextzugriff (PDF)

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

The lancet. Gastroenterology & hepatology, 2019-06, Vol.4 (6), p.454-465

2019

Volltextzugriff (PDF)

Prospective analysis of CEA, circulating DNA (cDNA) and circulating tumor cells (CTC) kinetics in patients (pts) treated for a metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3560-3560

2016

Volltextzugriff (PDF)

Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer

International journal of cancer, 2017-04, Vol.140 (7), p.1653-1661

2017

Volltextzugriff (PDF)

Plasma cell-free DNA and fraction of circulating KRAS mutations as prognostic in patients with metastatic colorectal cancer

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.490-490

2014

Volltextzugriff (PDF)

PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3541-3541

2015

Volltextzugriff (PDF)

Primary prophylactic granulocyte colony-stimulating factor (GCSF) in Gilbert’s disease patients treated with FOLFIRI first line for metastatic colorectal cancer (mCRC): Final results of the FFCD 0604 study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3614-3614

2013

Volltextzugriff (PDF)

Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.157-157

2013

Volltextzugriff (PDF)

Rectal cancer: situation where a referral center is needed

Bulletin du cancer, 2011-12, Vol.98 (12), p.1455

2011

Volltextzugriff (PDF)

Le cancer du rectum en situation de recours

Bulletin du cancer, 2011-12, Vol.98 (12), p.1455-1468

2011

Volltextzugriff (PDF)

Analyse préliminaire des risques appliquée au parcours patient nécessitant une endoscopie digestive programmée sous anesthésie générale

Le pharmacien hospitalier & clinicien, 2019-03, Vol.54 (1), p.98-98

2019

Volltextzugriff (PDF)

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design

Molecular therapy. Nucleic acids, 2018-06, Vol.11 (C), p.159-169

2018

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(23)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Percutaneous Biliary External–Internal Drainage for Malignant Obstruction of Self-Expanding Uncovered Metal Stents Placed for Hilar Carcinoma: Retrospective Analysis of Long-Term Outcome in 160 Patients

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer

Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis

Our challenge is to adapt the organization of our system to the six stages of the epidemic to go beyond the COVID‐19 crisis

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

Circulating DNA changes are predictive of disease progression after transarterial chemoembolization

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Prospective analysis of CEA, circulating DNA (cDNA) and circulating tumor cells (CTC) kinetics in patients (pts) treated for a metastatic colorectal cancer (mCRC)

Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer

Plasma cell-free DNA and fraction of circulating KRAS mutations as prognostic in patients with metastatic colorectal cancer

PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial

Primary prophylactic granulocyte colony-stimulating factor (GCSF) in Gilbert’s disease patients treated with FOLFIRI first line for metastatic colorectal cancer (mCRC): Final results of the FFCD 0604 study

Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis

Rectal cancer: situation where a referral center is needed

Le cancer du rectum en situation de recours

Analyse préliminaire des risques appliquée au parcours patient nécessitant une endoscopie digestive programmée sous anesthésie générale

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design

Suchergebnisse filtern